Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Wynn Resorts Ltd WYNN

Consumer Cyclical Resorts & Casinos
Wynn Resorts, Limited is a designer, developer, and operator of integrated resorts featuring luxury hotel rooms, high-end retail space, an array of dining and entertainment options, meeting and convention facilities, and gaming. Its segments include Wynn Palace, Wynn Macau, Las Vegas Operations, Encore Boston Harbor, and Wynn Interactive. Wynn Palace features a luxury hotel tower with a total... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:WYNN)

Wynn Resorts Announces Final Results of Tender Offer for Cash by Wynn Las Vegas, LLC for its 5.500% Senior Notes due 2025

Business Wire March 8, 2024

Wynn Las Vegas to Debut Culinary Festival, Revelry, Following The World's 50 Best Restaurants Awards

PR Newswire March 6, 2024

Wynn Resorts Announces Early Results of Tender Offer for Cash by Wynn Las Vegas, LLC for its 5.500% Senior Notes due 2025

Business Wire February 22, 2024

Wynn Resorts Announces Commencement of Tender Offer for Cash by Wynn Las Vegas, LLC for its 5.500% Senior Notes due 2025

Business Wire February 8, 2024

Wynn Resorts Announces Pricing of Private Add-On Offering of $400 Million Aggregate Principal Amount of Wynn Resorts Finance 7.125% Senior Notes due 2031

Business Wire February 8, 2024

Wynn Resorts Announces Private Add-On Offering of $400 Million of Wynn Resorts Finance 7.125% Senior Notes due 2031

Business Wire February 8, 2024

Wynn Resorts, Limited Reports Fourth Quarter and Year End 2023 Results

Business Wire February 7, 2024

Wynn Resorts Recognized on FORTUNE Magazine's 2024 List of World's Most Admired Companies

Business Wire February 1, 2024

Wynn Resorts Announces Fourth Quarter Earnings Release Date

Business Wire January 31, 2024
View More News ››

Opinion & Analysis (NDAQ:WYNN)

Casino ETF Keeps Landing On Red

Benzinga.com  September 17, 2014

Wynn Resorts (WYNN) wrestles with resistance

Andrea Kramer September 9, 2010

Wynn (WYNN) shakes off earnings-related losses

Andrea Kramer March 4, 2010

What the Chinese want even more than oil or gold

Braden Copeland January 26, 2010

Downside put sellers in WYNN and BUCY

Jud Pyle January 21, 2009
View More Opinion ››

Bullboard Posts (NDAQ:WYNN)

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
Maemae4 - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
Maemae4 - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
Maemae4 - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
Maemae4 - June 2, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
Maemae4 - May 11, 2022

Lucid-MS for Multiple Sclerosis Treatment

<< View Post To Watch Video >>
Maemae4 - May 3, 2022
View more Bullboard ››

Nurcapital Corporation Ltd.

Nurcapital Corporation Ltd.

Nurcapital was incorporated under the Business Corporations Act (Ontario) on January 8, 2015. The Company is listed as a ...
View More »